Skip to content

US · BDMD · MEDICAL - DEVICES

Baird Medical Investment Holdings Limited (BDMD) intrinsic value and stock valuation

$0.09as of 2026-11-21 · Mkt cap 45.16M

Data updated · price as of 2026-11-21

IC valuationIntrinsic value, upside vs price and the fair-value band are available to Pro members.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

Baird Medical Investment Holdings Limited DCF and intrinsic value

InvestorsCraft values BDMD with the Chepakovich two-stage DCF model. How the model works · Run your own DCF prefilled from BDMD’s statements →

Baird Medical Investment Holdings Limited Graham Number

The Graham Number is not defined for negative earnings or book value. Guide · Calculator →

Healthcare · Medical - Devices Guangzhou, GD 510000 bairdmed.com

How the business is doing

Fiscal 2019–2025, USD

Revenue
$22.5M+4.5% 5y CAGRd
20192025
Net income
-$-27.28M
20192025
Free cash flow
-$-1.39M
20192025
Total equity
$31.2M+35.8% 5y CAGRd
20192025

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Peers

Same-industry companies, ranked by market cap

Peer comparison

The peer comparison table is shown only to users with a Pro subscription.

Financials

Statements by fiscal year

Fiscal 2019–2025, USD
20252024202320222021
Revenue$22.5M$37M$31.5M$35.1M$27.7M
Operating income-$-25.54M$15.3M$11.9M$13.6M$11.9M
Net income-$-27.28M$12.5M$10.6M$12.6M$11.7M
EPSd-$-981.65K$485.8K$1.39M$1.75M$1.62M
Operating cash flow-$-1.34M-$-6.31M-$-1.02M$490K$5.26M
Capital expenditure-$-40K-$-2.85M-$-2.64M-$-5.95M-$-1.39M
Free cash flow-$-1.39M-$-9.17M-$-3.66M-$-5.47M$3.87M
Total assets$69.7M$78M$56.7M$42.6M$26.1M
Total debt$19.3M$20.9M$9.9M$7.44M$2.93M
Net debt$19.1M$17.9M$8.39M$5.73M-$-100K
Total equity$31.2M$39.8M$35.7M$25.8M$4.85M
Cash and short-term investments$180K$2.97M$1.63M$1.91M$3.44M
Income statement
20252024202320222021
Revenue$22.5M$37M$31.5M$35.1M$27.7M
Cost of revenue$3.65M$4.38M$4.23M$7.05M$4.54M
Gross profit$18.9M$32.7M$27.2M$28M$23.2M
Research and development expenses$20.1M$6.17M$4.27M$3.86M$1.04M
Selling, general and administrative expenses$24.4M$9.96M$11.1M$10.6M$10.2M
Other expenses-$-90K$1.2M$0.00$0.00$0.00
Operating expenses$44.4M$17.3M$15.4M$13M$9.76M
Cost and expenses$48.1M$21.7M$19.6M$20.1M$14.6M
Interest income$0.00$0.00$0.00$10K$0.00
Interest expense$740K$580K$280K$300K$150K
Depreciation and amortization$1.1M$1.51M$1.01M$1.47M$1.4M
Ebitda-$-24.53M$16.2M$12.9M$16.3M$14.2M
Operating income-$-25.54M$15.3M$11.9M$13.6M$11.9M
Total other income/expenses, net-$-840K-$-1.23M$500K$890K$690K
Income before tax-$-26.37M$14.1M$12.4M$14.5M$12.6M
Income tax expense$1.17M$1.49M$1.7M$1.75M$2.42M
Net income-$-27.28M$12.5M$10.6M$12.6M$11.7M
Weighted average shares outstanding$27.8M$25.6M$7.58M$6.29M$7.19M
Weighted average diluted shares outstanding$27.8M$25.6M$7.58M$7.19M$7.19M
Balance sheet
20252024202320222021
Cash and short-term investments$180K$2.97M$1.63M$1.91M$3.44M
Net receivables$42.5M$46.6M$31.5M$24.8M$12.5M
Inventory$1.09M$1.3M$1.14M$1.29M$3.06M
Total current assets$55M$61.4M$40.1M$33.8M$22.4M
Property, plant and equipment, net$6.55M$7.62M$7M$2.73M$3.33M
Goodwill and intangible assets$70K$70K$80K$110K$130K
Long-term investments$0.00$0.00-$-810K-$-210K-$-110K
Total non-current assets$14.7M$16.6M$16.6M$8.85M$3.72M
Total assets$69.7M$78M$56.7M$42.6M$26.1M
Accounts payable$1.81M$1.25M$550K$220K$340K
Short-term debt$13.2M$17.3M$9.49M$6.62M$2.44M
Deferred revenue$790K$790K$500K$690K$700K
Total current liabilities$32.4M$34.6M$19M$16M$9.77M
Long-term debt$6.11M$3.58M$410K$820K$490K
Deferred revenue, non-current$0.00$0.00$0.00$0.00$0.00
Total non-current liabilities$6.11M$3.58M$2.03M$820K$490K
Capital lease obligations$140K$400K$1.73M$1.21M$890K
Total liabilities$38.5M$38.2M$21M$16.8M$10.3M
Common stock$0.00$0.00$0.00$0.00$10K
Retained earnings-$-520K$26.8M$14.4M$3.96M-$-7.13M
Accumulated other comprehensive income (loss)$3.22M$1.45M$2.5M$3.12M$3.31M
Total equity$31.2M$39.8M$35.7M$25.8M$4.85M
Total investments$0.00$0.00-$-690K-$-10K$300K
Total debt$19.3M$20.9M$9.9M$7.44M$2.93M
Net debt$19.1M$17.9M$8.39M$5.73M-$-100K
Cash flow statement
20252024202320222021
Net income-$-27.54M$12.6M$10.6M$12.8M$10.2M
Depreciation and amortization$1.1M$1.51M$1.38M$1.47M$1.4M
Stock-based compensation$17.5M$0.00$0.00$0.00$0.00
Change in working capital$6.79M-$-21.7M-$-14.05M-$-14.05M-$-6.57M
Accounts receivable$5.35M-$-17.8M-$-9.67M-$-14.1M-$-3.49M
Inventory$260K-$-190K$110K$1.57M-$-2.2M
Accounts payable$480K$730K$0.00-$-100K$270K
Net cash provided by operating activities-$-1.34M-$-6.31M-$-1.02M$490K$5.26M
Investments in property, plant and equipment-$-40K-$-2.85M-$-2.64M-$-5.91M-$-1.39M
Acquisitions, net$0.00$0.00$0.00$0.00$0.00
Net cash used for investing activities-$-40K-$-2.85M-$-2.64M-$-5.92M-$-1.39M
Common stock issued$0.00$2.9M$0.00$0.00$0.00
Common stock repurchased$0.00$0.00$0.00$0.00$0.00
Dividends paid$0.00$0.00$0.00$0.00-$-5.43M
Net cash used for financing activities-$-1.39M$10.7M$3.46M$4.41M-$-1.93M
Net change in cash-$-2.4M$1.46M-$-200K-$-1.32M$1.96M
Cash at end of period$570K$2.97M$1.51M$1.71M$3.03M
Operating cash flow-$-1.34M-$-6.31M-$-1.02M$490K$5.26M
Capital expenditure-$-40K-$-2.85M-$-2.64M-$-5.95M-$-1.39M
Free cash flow-$-1.39M-$-9.17M-$-3.66M-$-5.47M$3.87M
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About Baird Medical Investment Holdings Limited

        Based in China, Baird Medical Investment Holdings Limited and its associated entities specialize in engineering and commercializing microwave ablation medical apparatus. These sophisticated instruments are employed in the minimally invasive management of a diverse array of benign and malignant tumors, notably targeting thyroid nodules, hepatic carcinomas, pulmonary cancers, and mammary lesions. The organization was established in 2012, with its corporate headquarters situated in Guangzhou, China.

        CEO
        Haimei Wu
        Employees
        146
        Beta
        -1.17

        Explore

        Frequently asked questions

        What is the intrinsic value of Baird Medical Investment Holdings Limited (BDMD)?

        InvestorsCraft does not currently publish an intrinsic value for BDMD. How the IC value is calculated.

        Is BDMD undervalued?

        InvestorsCraft does not publish an undervaluation signal for BDMD at this time.

        How is the intrinsic value calculated?

        InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.

        How often is this page updated?

        Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.